MedTrace Logo

BioButton Among Nursing Home Residents

NCT06665685 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 17

Last updated 2026-01-12

No results posted yet for this study

Summary

This pilot study will explore the use of the BioIntellisense BioButton, a remote wearable multi-parameter monitor, to identify gait disturbances that occur as a side effect of polypharmacy.

Conditions

  • Gait
  • Medication Induced Gait Disturbances

Interventions

DEVICE

BioButton Device

BioButton is a remote wearable multi-parameter monitor, to identify gait disturbances that occur as a side effect of polypharmacy. This arm will be the patient wearing the device during their Nursing Home stay for 30-days.

DEVICE

Providing Clinical Care with BioButton Device

BioButton is a remote wearable multi-parameter monitor, to identify gait disturbances that occur as a side effect of polypharmacy. This arm will provide care for patients wearing the BioButton device during their Nursing Home stay for 30-days.

Sponsors & Collaborators

  • Charles Lin

    lead OTHER

  • Jewish Healthcare Foundation

    collaborator UNKNOWN

Principal Investigators

  • Charles Lin, MD · UPMC, University of Pittsburgh

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-03-11
Primary Completion
2025-07-18
Completion
2025-07-18
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06665685 on ClinicalTrials.gov